Skip to main content
. 2013 Apr 23;5(3):194–204. doi: 10.4021/jocmr1376w

Table 4. Trends in Medication Use in Patients With HFpEF .

ACE-I/ ARBs Aldosterone Antagonists Aspirin Beta Blockers Calcium Channel Blockers Digoxin Diuretics Nitrates Statins
Pre-Hospital (%)
  1995 34.7 N/A 22.8 27.7 49.5 33.7 78.2 39.6 8.9
  2000 38.2 N/A 40.8 41.2 39.0 29.2 78.7 27.0 19.5
  2002 46.3 6.4 37.2 57.9 32.6 25.6 83.2 25.9 32.9
  2004 52.3 6.6 45.6 62.0 33.8 22.3 81.5 21.6 40.8
In-Hospital (%)
  1995 45.0 N/A 45.0 29.8 56.7 45.0 98.8 68.4 5.3
  2000 49.1 N/A 57.6 51.6 45.1 35.3 97.8 59.8 20.3
  2002 48.2 7.5 59.4 62.4 37.6 29.6 97.6 51.1 28.1
  2004 56.8 5.6 61.5 70.5 40.6 22.7 97.7 42.4 40.3
Discharge (%)
  1995 36.7 N/A 38.0 25.3 43.0 39.9 76.0 39.2 5.1
  2000 43.5 N/A 47.8 44.9 35.2 27.2 74.0 25.3 20.6
  2002 41.7 6.4 46.2 54.9 28.1 23.7 76.9 22.0 25.9
  2004 46.6 3.7 46.2 62.8 31.8 15.8 77.1 16.6 38.4

Pre-hospital data excludes incident cases of acute HF; Hospital discharge data excludes hospital decedents; ACE-I/ARBs = angiotensin converting enzyme inhibitors or angiotensin receptor blockers.